Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cabazitaxel in Platinum Refractory Ovarian Cancer

This study has been terminated.
(Too low inclusion rate. Only 4 patients included over 16 months)
Information provided by (Responsible Party):
Vejle Hospital Identifier:
First received: December 6, 2012
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)